Literature DB >> 21306263

Ranibizumab for age-related macular degeneration.

Jin-Wei Cheng, Rui-Li Wei.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21306263     DOI： 10.1056/NEJMc1013316

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  5 in total

1.  An outbreak of streptococcus endophthalmitis after intravitreal injection of bevacizumab.

Authors:  Roger A Goldberg; Harry W Flynn; Ryan F Isom; Darlene Miller; Serafin Gonzalez
Journal:  Am J Ophthalmol       Date:  2012-02       Impact factor: 5.258

2.  Growth of Scytalidium sp. in a counterfeit bevacizumab bottle.

Authors:  Gerardo Garcia-Aguirre; Virginia Vanzinni-Zago; Hugo Quiroz-Mercado
Journal:  Indian J Ophthalmol       Date:  2013-09       Impact factor: 1.848

3.  A Large Outbreak of Fulminant Bacterial Endophthalmitis after Intravitreal Injection of Counterfeit Bevacizumab.

Authors:  Morteza Entezari; Saeed Karimi; Hamid Ahmadieh; Amir Hossein Mahmoudi; Hamid Parhizgar; Mehdi Yaseri
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-07-04       Impact factor: 3.117

4.  Lasting controversy on ranibizumab and bevacizumab.

Authors:  Lihui Zou; Huiying Lai; Qi Zhou; Fei Xiao
Journal:  Theranostics       Date:  2011-12-12       Impact factor: 11.556

5.  Intravitreal administration of bevacizumab: pros and cons.

Authors:  Simin Dashti-Khavidaki; Mohammad Abdollahi
Journal:  Daru       Date:  2015-04-21       Impact factor: 3.117
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.